The FDA announced that they will allow Emergent BioSolutions to resume production of the Johnson and Johnson covid-19 vaccine on Thursday.
Emergent Biosolutions To Resume Production Of Johnson & Johnson COVID-19 Vaccine
The FDA announced that they will allow Emergent Biosolutions to resume production of the Johnson and Johnson covid-19 vaccine on..
WJZ Baltimore